Thailand on Friday delayed the usage of the AstraZeneca made coronavirus vaccine as a precautionary measure after 9 European nations, together with Iceland, Denmark, Norway, Bulgaria, Estonia and Latvia, briefly suspended the jabs over blood clot considerations.
The delay was based mostly on the choice made by Denmark, Austria and others as a precaution, stated the Thai well being officers.
Austria whereas investigating demise from coagulation issues has stopped utilizing a batch of AstraZeneca pictures.
The different specialists, nevertheless, said there have been no reported circumstances of the vaccine inflicting blood clots or associated issues elsewhere, together with in Britain.
READ: After Six Month Hiatus, Chinese App TikTok Banned In Pakistan Again Over Profanity Claims
Yong Poovorawan, an advisor to Thailand’s vaccination program, stated the delay, pending an investigation into the reason for the reported aspect impact, is not going to have a huge impact on the rollout, the Associated Press (AP) reported.
Earlier on Thursday, the European Medicines Agency stated that there was no indication of the jab inflicting blood clots and added its advantages proceed to outweigh its dangers.
READ: First ‘Single-Shot’ Coronavirus Vaccine By Johnson & Johnson Gets EU Approval
Aiming to inject 10 million doses a month from June, Thailand plans to cowl not less than half its inhabitants by the top of 2021.
Thailand started its vaccination drive earlier in February with an preliminary 200,000 doses of China’s Sinovac and 117,000 doses of AstraZeneca.
